Effects of the COVID-19 Pandemic on the Gastrointestinal Cancer Stage at Diagnosis in Japa
- Conditions
- Gastrointestinal Cancer
- Registration Number
- JPRN-UMIN000043873
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine
- Brief Summary
The study evaluated 5167 patients. Comparing the preCOVID-19 period with the COVID-19 period, significant decreases were observed in the mean number of patients with newly diagnosed gastric cancer and colorectal cancer. Significant decreases were also observed in the mean number of cases of stage I gastric cancer, stage 0 colorectal cancer, and stage I colorectal cancer. A significant decrease was observed in the mean number of cases per month of stage II colorectal cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5167
Not provided
Patients were considered eligible if they were diagnosed or started their first treatment (including palliative care) at the study hospitals and were considered ineligible if they were diagnosed and started their first treatment at other hospitals.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method